Pre-Made Insulin Efsitora Alfa Biosimilar, Fusion Protein targeting INSR fused with human IGHG2 Fc (Fragment constant): Recombinant therapeutic protein targeting CD220/HHF5 for drug discovery and mechanism of action (MOA) research

Cat:GMP-Bios-INN-870

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

SKU GMP-Bios-INN-870 Category Tag

Product Details

Pre-Made Insulin Efsitora Alfa Biosimilar, Fusion Protein targeting INSR fused with human IGHG2 Fc (Fragment constant): Recombinant therapeutic protein targeting CD220/HHF5 is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Insulin Efsitora Alfa is a human insulin B-chain fused via a G2SG4 peptide linker to human insulin A-chain variant and a peptide linker to a human immunoglobulin G2 Fc fragment. It is used as an antidiabetic drug.

Products Name (INN Index)

Pre-Made Insulin Efsitora Alfa Biosimilar, Fusion Protein targeting INSR fused with human IGHG2 Fc (Fragment constant): Recombinant therapeutic protein targeting CD220/HHF5

INN Name

insulin efsitora alfa

Target

INSR

Format

Fusion Protein

Derivation

Human

Species Reactivity

Human

CH1 Isotype

Fusion – INS (insulin, IDDM1, IDDM2, "insulin- dependent diabetes mellitus 2") – IGHG2 Fc (Fragment constant)

VD LC

Fusion – INS (insulin, IDDM1, IDDM2, "insulin- dependent diabetes mellitus 2") – IGHG2 Fc (Fragment constant)

Highest_Clin_Trial (Jan '20)

NA

Est. Status

NA

100% SI Structure

NA

99% SI Structure

NA

95-98% SI Structure

NA

Year Proposed

NA

Companies

Eli?Lilly (Indianapolis IN USA)

Conditions Approved

NA

Conditions Active

NA

Conditions Discontinued

NA

Development Tech

NA

Previous Name

NA

Gm Offical Target Name

INSR

Package

, ,

Genemeidi Omicron Variant Products
test
Previous slide
Next slide